For the last few years much interest and effort has been invested to better understand the first tier emerging markets of Brazil, Russia, India and China. But as that understanding matures, the spotlight is increasingly being cast on tier two markets that combine large populations with low median age, significant unmet clinical need, and rising economic performance. These markets have become known collectively since 2009 by the acronym CIVETS.